Is it time US dentistry ended its opioid dependence?
- PMID: 31561762
- PMCID: PMC7951996
- DOI: 10.1016/j.adaj.2019.07.003
Is it time US dentistry ended its opioid dependence?
Abstract
Background: In 2017, 11.4 million US citizens misused prescription opioids, resulting in 46 overdose deaths daily and a $78.5 billion burden on the economy. Dentists are one of the most frequent prescribers of opioids, and there is concern that dental prescribing is contributing to the opioid crisis.
Methods: A 2019 study showed 22.3% of US dental prescriptions were for opioids compared with 0.6% of dental prescriptions in England where nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen accounted for most analgesic prescriptions. This observation prompted a review of international analgesic prescribing habits and of the advantages and disadvantages of opioids and NSAIDs for treating dental pain.
Results: US opioid prescribing far exceeded that in other countries where NSAIDs accounted for most dental analgesic prescribing. Furthermore, results from reviews published respectively in 2018 and 2016 help confirm that NSAIDs and NSAID-acetaminophen combinations are as effective as or more effective than opioids for controlling dental pain and cause significantly fewer adverse effects.
Conclusions: In light of the potential for misuse and evidence that NSAIDs are as effective as opioids and have fewer adverse effects, there is clear patient benefit in avoiding opioids for the prevention or management of dental pain.
Practical implications: A growing preponderance of evidence shows that opioids are not needed for routine oral health care. This article provides an overview of the evidence and outlines possible pain management models to minimize opioid use in dentistry. The purpose is to stimulate debate about this important topic and encourage the development of definitive guidance by professional bodies, health care providers, and state and federal agencies.
Keywords: Odontogenic pain; acetaminophen; analgesic; dental; guidelines; nonsteroidal anti-inflammatory drugs; opioid; opioid crisis; postoperative analgesia.
Copyright © 2019 American Dental Association. Published by Elsevier Inc. All rights reserved.
Comment in
-
Nonsteroidal Anti-Inflammatory Drug Risks.J Am Dent Assoc. 2020 Jan;151(1):4-5. doi: 10.1016/j.adaj.2019.11.008. J Am Dent Assoc. 2020. PMID: 31902398 No abstract available.
References
-
- US Department of Health and Human Services. HHS acting secretary declares public health emergency to address national opioid crisis [press release]. Available at: https://www.hhs.gov/about/news/2017/10/26/hhs-acting-secretary-declares-.... Accessed April 7, 2019.
-
- Centers for Disease Control and Prevention, National Center for Health Statistics. Prescription opioid analgesic use among adults: United States, 1999–2012. Available at: https://www.cdc.gov/nchs/products/databriefs/db189.htm. Accessed April 21, 2019.
-
- Centers for Disease Control and Prevention. Prescription opioid data. NCHS data brief 189. Available at: https://www.cdc.gov/drugoverdose/data/prescribing.html. Accessed April 7, 2019.
-
- US Department of Health and Human Services. What is the U.S. opioid epidemic? Available at: https://www.hhs.gov/opioids/about-the-epidemic/index.html. Accessed April 7, 2019.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
